Adjuvant external radiation therapy following radical prostatectomy for node-negative prostate cancer

Current Opinion in Urology

Volumn 13, Issue 2, 2003, Pages 117-122

  Davis, Brian J ^a   Pisansky, Thomas M ^a   Leibovich, Bradley C ^b  

^a MAYO CLINIC   (United States)

^b DEPARTMENT OF UROLOGY   (United States)

Author keywords

Prostatectomy; Prostatic neoplasms; Radiation therapy

Indexed keywords

ADJUVANT THERAPY; CANCER RECURRENCE; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; REVIEW; URINE INCONTINENCE;

HUMANS; LYMPHATIC METASTASIS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 0037335179     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200303000-00006     Document Type: Review

References (44)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
2. Harlan LC, Potosky A, Gilliland FD, et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001; 93:1864-1871.
3. Nasr R, Goldenberg SL. Rising prostate specific antigen after radical prostatectomy: a case based review. Can J Urol 2001; 8:1306-1313.
4. Mettlin CJ, Murphy GP, Rosenthal DS, et al. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998; 83:1679-1684.
5. Amling CL, Blute ML, Bergstralh EJ, et al. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 2000; 164:101-105.
6. Lu-Yao GL, Potosky AL, Albertsen PC, et al. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst 1996; 88:166-173.
7. Anscher MS. Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen. Int J Cancer 2001; 96:91-93. This article elucidates the rationale for immediate adjuvant radiation therapy.
8. Schild SE. Radiation therapy (RT) after prostatectomy: the case for salvage therapy as opposed to adjuvant therapy. Int J Cancer 2001; 96:94-98.
9. Schild SE, Pisansky TM. The role of radiotherapy after radical prostatectomy. Urol Clin North Am 2001; 28:629-637, x.
10. Schild SE, Wong WW, Grado GL, et al. The result of radical retropubic prostatectomy and adjuvant therapy for pathologic stage C prostate cancer. Int J Radiat Oncol Biol Phys 1996; 34:535-541.
11. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997; 337:949-955.
12. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337:956-962.
13. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 1999; 73:177-183.
14. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345:725-730.
15. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998; 280:1485-1489.
16. McCarter MD, Jaques DP, Brennan MF. Randomized clinical trials in soft tissue sarcoma. Surg Oncol Clin N Am 2002; 11:11-22.
17. Hall EJ, Astor M, Bedford J, et al. Basic radiobiology. Am J Clin Oncol 1988; 11:220-252.
18. Bentzen SM. Quantitative clinical radiobiology. Acta Oncol 1993; 32:259-275.
19. Valicenti RK, Gomella LG, Ismail M, et al. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 1999; 45:53-58.
20. Blute ML, Bergstralh EJ, Iocca A, et al. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 2001; 165:119-125. This analysis includes a detailed multivariate analysis of factors associated with prostate cancer recurrence following prostatectomy. The analysis also identifies adjuvant androgen deprivation therapy and radiotherapy as factors associated with decreasing recurrence.
21. Catton C, Gospodarowicz M, Warde P, et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 2001; 59:51-60. This article compares the authors' series of adjuvant and salvage radiotherapy.
22. Thompson I, Crawford E, Miller G, et al. Adjuvant radiotherapy following radical prostatectomy for pathologic stage C adenocarcinoma of the prostate; initial evaluation of toxicity. Proc Ann Meeting Soc Clin Oncol 1992; 11:1-212.
23. Sakr WA, Wheeler TM, Blute M, et al. Staging and reporting of prostate cancer: sampling of the radical prostatectomy specimen. Cancer 1996; 78:366-368.
24. Koppie TM, Grossfeld GD, Nudell DM, et al. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy? J Urol 2001; 166:111-115. The authors conclude that anastomotic biopsy is not essential before radiotherapy.
25. Zelefsky MJ, Fuks Z, Leibel SA. Intensity-modulated radiation therapy for prostate cancer. Semin Radiat Oncol 2002; 12:229-237. A review of intensity modulated radiation therapy for prostate cancer including the Memorial Sloan-Kettering Cancer Center experience.
26. Thompson IM, Paradelo JC, Crawford ED, et al. An opportunity to determine optimal treatment of pT3 prostate cancer: the window may be closing. Urology 1994; 44:804-811.
27. Van Cangh PJ, Richard F, Lorge F, et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study. J Urol 1998; 159:164-166.
28. Choo R, Hruby G, Hong J, et al. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not? Int J Radiat Oncol Biol Phys 2002; 52:674-680. Postoperative adjuvant radiotherapy was associated with a lower risk of relapse compared with observation.
29. Teh BS, Mai WY, Augspurger ME, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001; 49:465-472. This article reports the genitourinary side effect profile of adjuvant radiotherapy compared with primary radiotherapy with intensity-modulated radiation therapy.
30. Bastasch MD, Teh BS, Mai WY, et al. Post-nerve-sparing prostatectomy, dose-escalated intensity-modulated radiotherapy: effect on erectile function. Int J Radiat Oncol Biol Phys 2002; 54:101-106. This study reports early follow-up on the effects of adjuvant radiotherapy on erectile function.
31. Formenti SC, Lieskovsky G, Skinner D, et al. Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy. Urology 2000; 56:453-458.
32. Valicenti RK, Gomella LG, Ismail M, et al. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. Urology 1998; 52:1034-1040.
33. Coetzee LJ, Hats V, Paulson DF. Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy. Urology 1996; 47:232-235.
34. Leibovich BC, Engen DE, Patterson DE, et al. Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin. J Urol 2000; 163:1178-1182.
35. Do LV, Do TM, Smith R, et al. Postoperative radiotherapy for carcinoma of the prostate: impact on both local control and distant disease-free survival. Am J Clin Oncol 2002; 25:1-8.
36. Myers RP, Fleming TR. Course of localized adenocarcinoma of the prostate treated by radical prostatectomy. Prostate 1983; 4:461-472.
37. Morris MM, Dallow KC, Zietman AL, et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38:731-736.
38. Valicenti RK, Gomella LG, Ismail M, et al. Pathologic seminal vesicle invasion after radical prostateotomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control. Cancer 1998; 82:1909-1914.
39. Davis BJ, Cheville JC, Wilson TM, et al. Histopathologic characterization of seminal vesicle invasion in prostate cancer: implications for radiotherapeutic management. Int J Radiat Oncol Biol Phys 2001; 51:140-141.
40. Petrovich Z, Lieskovsky G, Langholz B, et al. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53:600-609. The authors report their long experience using radiotherapy in the adjuvant setting.
41. Mayer R, Pummer K, Quehenberger F, et al. Postprostatectomy radiotherapy for high-risk prostate cancer. Urology 2002; 59:732-739.
42. Anscher MS, Prosnitz LR. Multivariate analysis of factors predicting local relapse after radical prostatectomy: possible indications for postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21:941-947.
43. Lowe BA, Lieberman SF. Disease recurrence and progression in untreated pathologic stage T3 prostate cancer: selecting the patient for adjuvant therapy. J Urol 1997; 158:1452-1456.
44. Stamey T, Yang N, Hay A. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317:909-916.